BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 24774721)

  • 1. Randomized phase II trial of hypofractionated proton versus carbon ion radiation therapy in patients with sacrococcygeal chordoma-the ISAC trial protocol.
    Uhl M; Edler L; Jensen AD; Habl G; Oelmann J; Röder F; Jäckel O; Debus J; Herfarth K
    Radiat Oncol; 2014 Apr; 9():100. PubMed ID: 24774721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised trial of proton vs. carbon ion radiation therapy in patients with chordoma of the skull base, clinical phase III study HIT-1-Study.
    Nikoghosyan AV; Karapanagiotou-Schenkel I; Münter MW; Jensen AD; Combs SE; Debus J
    BMC Cancer; 2010 Nov; 10():607. PubMed ID: 21054824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose carbon-ion based radiotherapy of primary and recurrent sacrococcygeal chordomas: long-term clinical results of a single particle therapy center.
    Bostel T; Mattke M; Nicolay NH; Welzel T; Wollschläger D; Akbaba S; Mayer A; Sprave T; Debus J; Uhl M
    Radiat Oncol; 2020 Aug; 15(1):206. PubMed ID: 32831113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised trial of proton vs. carbon ion radiation therapy in patients with low and intermediate grade chondrosarcoma of the skull base, clinical phase III study.
    Nikoghosyan AV; Rauch G; Münter MW; Jensen AD; Combs SE; Kieser M; Debus J
    BMC Cancer; 2010 Nov; 10():606. PubMed ID: 21050498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant irradiation of extremity soft tissue sarcoma with ions (Extrem-ion): study protocol for a randomized phase II pilot trial.
    Brügemann D; Lehner B; Kieser M; Krisam J; Hommertgen A; Jaekel C; Harrabi SB; Herfarth K; Mechtesheimer G; Sedlaczek O; Egerer G; Geisbüsch A; Uhl M; Debus J; Seidensaal K
    BMC Cancer; 2022 May; 22(1):538. PubMed ID: 35550036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant irradiation of retroperitoneal soft tissue sarcoma with ions (Retro-Ion): study protocol for a randomized phase II pilot trial.
    Seidensaal K; Kieser M; Hommertgen A; Jaekel C; Harrabi SB; Herfarth K; Mechtesheimer G; Lehner B; Schneider M; Nienhueser H; Fröhling S; Egerer G; Debus J; Uhl M
    Trials; 2021 Feb; 22(1):134. PubMed ID: 33579340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbon ion beam treatment in patients with primary and recurrent sacrococcygeal chordoma.
    Uhl M; Welzel T; Jensen A; Ellerbrock M; Haberer T; Jäkel O; Herfarth K; Debus J
    Strahlenther Onkol; 2015 Jul; 191(7):597-603. PubMed ID: 25737378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Particle therapy using carbon ions or protons as a definitive therapy for patients with primary sacral chordoma.
    Mima M; Demizu Y; Jin D; Hashimoto N; Takagi M; Terashima K; Fujii O; Niwa Y; Akagi T; Daimon T; Hishikawa Y; Abe M; Murakami M; Sasaki R; Fuwa N
    Br J Radiol; 2014 Jan; 87(1033):20130512. PubMed ID: 24288399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ion Prostate Irradiation (IPI) - a pilot study to establish the safety and feasibility of primary hypofractionated irradiation of the prostate with protons and carbon ions in a raster scan technique.
    Habl G; Hatiboglu G; Edler L; Uhl M; Krause S; Roethke M; Schlemmer HP; Hadaschik B; Debus J; Herfarth K
    BMC Cancer; 2014 Mar; 14():202. PubMed ID: 24641841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute Toxicity and Quality of Life in Patients With Prostate Cancer Treated With Protons or Carbon Ions in a Prospective Randomized Phase II Study--The IPI Trial.
    Habl G; Uhl M; Katayama S; Kessel KA; Hatiboglu G; Hadaschik B; Edler L; Tichy D; Ellerbrock M; Haberer T; Wolf MB; Schlemmer HP; Debus J; Herfarth K
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):435-443. PubMed ID: 27084659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective phase-II-study evaluating postoperative radiotherapy of cervical and endometrial cancer patients using protons - the APROVE-trial.
    Arians N; Lindel K; Krisam J; Herfarth K; Krug D; Akbaba S; Oelmann-Avendano J; Debus J
    Radiat Oncol; 2017 Nov; 12(1):188. PubMed ID: 29179751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbon ion radiotherapy for chordomas and low-grade chondrosarcomas of the skull base. Results in 67 patients.
    Schulz-Ertner D; Nikoghosyan A; Thilmann C; Haberer T; Jäkel O; Karger C; Scholz M; Kraft G; Wannenmacher M; Debus J
    Strahlenther Onkol; 2003 Sep; 179(9):598-605. PubMed ID: 14628125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbon Ion Radiation Therapy for Unresectable Sacral Chordoma: An Analysis of 188 Cases.
    Imai R; Kamada T; Araki N;
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):322-327. PubMed ID: 27084649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: the CINDERELLA trial.
    Combs SE; Burkholder I; Edler L; Rieken S; Habermehl D; Jäkel O; Haberer T; Haselmann R; Unterberg A; Wick W; Debus J
    BMC Cancer; 2010 Oct; 10():533. PubMed ID: 20925951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The preliminary results of proton and carbon ion therapy for chordoma and chondrosarcoma of the skull base and cervical spine.
    Guan X; Gao J; Hu J; Hu W; Yang J; Qiu X; Hu C; Kong L; Lu JJ
    Radiat Oncol; 2019 Nov; 14(1):206. PubMed ID: 31752953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled phase III study comparing hadrontherapy with carbon ions versus conventional radiotherapy - including photon and proton therapy - for the treatment of radioresistant tumors: the ETOILE trial.
    Balosso J; Febvey-Combes O; Iung A; Lozano H; Alloh AS; Cornu C; Hervé M; Akkal Z; Lièvre M; Plattner V; Valvo F; Bono C; Fiore MR; Vitolo V; Vischioni B; Patin S; Allemand H; Gueyffier F; Margier J; Guerre P; Chabaud S; Orecchia R; Pommier P
    BMC Cancer; 2022 May; 22(1):575. PubMed ID: 35606739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protons versus photons for the treatment of chordoma.
    El Sayed I; Trifiletti DM; Lehrer EJ; Showalter TN; Dutta SW
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013224. PubMed ID: 34196007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of carbon ion radiotherapy in 152 patients.
    Schulz-Ertner D; Nikoghosyan A; Thilmann C; Haberer T; Jäkel O; Karger C; Kraft G; Wannenmacher M; Debus J
    Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):631-40. PubMed ID: 14751537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensity-modulated radiotherapy of sacral chordoma--a case report and a comparison with stereotactic conformal radiotherapy.
    Thilmann C; Schulz-Ertner D; Zabel A; Herfarth KK; Wannenmacher M; Debus J
    Acta Oncol; 2002; 41(4):395-9. PubMed ID: 12234033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose proton-based radiation therapy in the management of spine chordomas: outcomes and clinicopathological prognostic factors.
    Rotondo RL; Folkert W; Liebsch NJ; Chen YL; Pedlow FX; Schwab JH; Rosenberg AE; Nielsen GP; Szymonifka J; Ferreira AE; Hornicek FJ; DeLaney TF
    J Neurosurg Spine; 2015 Dec; 23(6):788-97. PubMed ID: 26340383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.